mk 0663 has been researched along with Sensitivity and Specificity in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, N; Ji, W; Wen, Q; Zhang, X | 1 |
| Gammaitoni, A; Jensen, MP; Peloso, PM; Schnitzer, TJ; Smugar, SS; Wang, H | 1 |
| Bräutigam, L; Geisslinger, G; Nefflen, JU | 1 |
| Brune, K; Hinz, B; Lambrecht, C; Werner, D; Werner, U | 1 |
| Koteshwara, M; Ramakrishna, NV; Vishwottam, KN; Wishu, S | 1 |
1 trial(s) available for mk 0663 and Sensitivity and Specificity
| Article | Year |
|---|---|
Rapid quantitative analysis of etoricoxib in human plasma by UPLC-MS/MS and application to a pharmacokinetic study in Chinese healthy volunteers.
Topics: Adult; China; Chromatography, High Pressure Liquid; Etoricoxib; Female; Humans; Linear Models; Male; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2019 |
4 other study(ies) available for mk 0663 and Sensitivity and Specificity
| Article | Year |
|---|---|
Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlled trials of etoricoxib.
Topics: Adult; Aged; Chronic Disease; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Etoricoxib; Female; Humans; Low Back Pain; Male; Middle Aged; Pain Measurement; Pyridines; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sulfones; Treatment Outcome; Weights and Measures | 2012 |
Determination of etoricoxib in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionisation.
Topics: Antipyrine; Chromatography, Liquid; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Pyridines; Reference Standards; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Sulfones | 2003 |
A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma.
Topics: Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Etoricoxib; Humans; Isoxazoles; Male; Mass Spectrometry; Pyridines; Sensitivity and Specificity; Sulfonamides; Sulfones | 2005 |
Validated liquid chromatographic ultraviolet method for the quantitation of Etoricoxib in human plasma using liquid-liquid extraction.
Topics: Chromatography, High Pressure Liquid; Cyclooxygenase Inhibitors; Drug Stability; Etoricoxib; Humans; Pyridines; Reproducibility of Results; Sensitivity and Specificity; Sulfones | 2005 |